Essayer OR - Gratuit
Glenmark arm inks $700 mn licensing deal with AbbVie
Business Standard
|July 11, 2025
In what can be called a landmark deal for Indian pharma and research, IGI Therapeutics SA, a wholly-owned subsidiary of New York-based Ichnos Glenmark Innovation Inc. (IGI), signed an exclusive licensing agreement with US-based AbbVie for its oncology and autoimmune diseases asset ISB 2001 for an upfront payment of $700 million (₹6000 crore) and milestone-based payments of up to $1.2 billion (close to ₹10,000 crore).
ISB 2001, an investigational asset, has been developed using IGI's proprietary BEAT protein platform for oncology and autoimmune diseases.
Cette histoire est tirée de l'édition July 11, 2025 de Business Standard.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Business Standard
Business Standard
Act East must be zoned for Northeast: Sangma
Conrad Sangma is Meghalaya’s longest-serving chief minister (CM). In his ninth year as the northeastern state’s CM, Sangma, 48, has in recent months sought to redouble his government's efforts to attract investments.
3 mins
May 18, 2026
Business Standard
'Markets at risk of further downside if oil prices stay elevated'
Mid and smallcap stocks may struggle to outperform largecaps over the next year as valuations in both segments remain significantly above historical averages, says Ajay Tyagi, senior executive vice-president and head-equity at UTI AMC.
2 mins
May 18, 2026
Business Standard
Power ministry working on tariff redesign
Tweak in fixed charges also in pipeline
2 mins
May 18, 2026
Business Standard
Rupee hitting 100/$? Not soon, say experts
Even as the rupee hits fresh lows and remains under pressure, most market participants believe it is unlikely to breach the psychologically significant 100-per-dollar mark anytime soon unless oil prices remain high and foreign outflows continue.
3 mins
May 18, 2026
Business Standard
India-Netherlands seal ‘strategic partnership’ pact
The two nations sign 17 deals during Modi’s two-day visit to The Hague, writes Archis Mohan
2 mins
May 18, 2026
Business Standard
Centre tapping Big Tech companies for data centres, R&D in West Bengal
The central government has approached global technology majors such as Google, Amazon and Microsoft, along with Indian conglomerates like Reliance Industries and the Adani Group, to push investments in data centres, hyperscalers, and research and development (R&D) hubs in West Bengal.
2 mins
May 18, 2026
Business Standard
‘Don’t think India wants to move towards stringent capital controls’
purely in the spot market to curb volatility but also through forwards, thus avoiding dramatic foreign exchange reserve draw
3 mins
May 18, 2026
Business Standard
Biosimilars could surpass generics in US mkt by early 2030s: Dr Reddy's CEO
Dr Reddy’s Lab is positioning itself for the next phase of growth through its global semaglutide strategy, expansion plans in biosimilars and peptides, and the road map for its North American business beyond traditional generics, said Erez Israeli, chief executive officer, in an exclusive video interaction with Anjali Singh and Sanket Koul.
4 mins
May 18, 2026
Business Standard
Silver ETFs may turn premium after import curbs
MFs eye further clarity, expect physical silver supply constraints if demand shoots up
2 mins
May 18, 2026
Business Standard
Skewed priorities in priority lending
The Economic Advisory Council to the Prime Minister has called for a revamp of the priority-sector lending (PSL) framework, shifting focus from economic efficiency to social equity.
1 min
May 18, 2026
Listen
Translate
Change font size